Mr. Chris Cleary

Biography

Chris Cleary is Vice President of Corporate Development for Medtronic.  During 2014, Chris led the corporate development efforts for Medtronic’s $49B acquisition of Covidien.  Since then, Medtronic has acquired over 30 businesses, most recently HeartWare, for a total of more than $4 billion, and has also made more than 25 investments in companies and funds in excess of $200 million. Prior  to  2014,  Chris  was  CEO  for  Alesia  Capital Services   LLC,   providing   advisory   and   financial analysis  services  to  Fortune  500  companies  including  Medtronic,  Ally, Macquarie Capital, Everbank, Goldman Sachs and Genpact. Chris worked at GE Capital from 1995 to 2011, leading M&A teams that closed acquisitions worth $60 billion of financial assets across more than 200 transactions in the United States, Canada, Chile, France, United Kingdom, Germany, Japan, Australia, Thailand and China. Chris also led numerous dispositions while at GE Capital, including the sale of GE Access to Avnet; the sale of HNS Banco to Rabobank; the sale of Cantrex and Corbeil to Sears Canada; the sale of $1B+ IKON copier lease portfolio to Bank of America; and the sale of GE Capital’s CLEC businesses to Eschelon Telecom. In 2009, Chris managed GE Capital Americas’ commercial wholesale finance platform focused on Construction, Agriculture, Transportation and Industrial markets, completing a complex integration from multiple GE Capital and Citicapital platforms Chris graduated from The Colorado College with a degree in Biology. He received the GE Capital Chairman’s Award for M&A excellence, and was a member of the General Electric Business Development senior leadership council.

Research Interest

Biotechnolgy